Malignant clinical features of anaplastic gliomas without IDH mutation

BACKGROUND: Diagnosis of WHO grade III anaplastic gliomas does not always correspond to its clinical outcome because of the isocitrate dehydrogenase (IDH) gene status. Anaplastic gliomas without IDH mutation result in a poor prognosis, similar to grade IV glioblastomas. However, the malignant featur...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Shibahara, Ichiyo, Sonoda, Yukihiko, Shoji, Takuhiro, Kanamori, Masayuki, Saito, Ryuta, Inoue, Tomoo, Kawaguchi, Tomohiro, Yamashita, Yoji, Watanabe, Takashi, Kumabe, Toshihiro, Watanabe, Mika, Suzuki, Hiroyoshi, Tominaga, Teiji
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2015
Aiheet:
Clinical Investigations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483044/
https://ncbi.nlm.nih.gov/pubmed/24958096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou112
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia